Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Oesophago-gastric Cancer × Panitumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 9 Esophageal Neoplasms 4 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Ovarian Neoplasms 1 Oesophago-gastric Cancer 1 KRAS and NRAS Wild-type Colorectal Cancer 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Cone Dystrophy 3 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Breast Neoplasms 1 Advanced Colorectal Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡